Juliana Santos

Dr. Juliana Santos

Josep Carreras Leukaemia Research Institute (IJC)
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JSJuliana Santos
Juliana Santos
Natalia da Silva LimaNatalia da Silva Lima
Natalia da Silva Lima
LSLuís Otávio Sarian
Luís Otávio Sarian
AMAnder Matheu
Ander Matheu
MRMarcelo Ribeiro
Marcelo Ribeiro
SDSophie Françoise Mauricette Derchain
Sophie Françoise Mauricette Derchain
Breast cancer remains the most prevalent cause of cancer mortality in woman worldwide due to the metastatic process and therapy resistance. Resistance against cancer therapy is partially attributed to cancer stem cells (CSCs). These cells arise from epithelial cells undergoing epithelial-to-mesenchymal transition (EMT) and might be responsible for tumor recurrence. In this study, we reported the relevance of miR-155 upregulation in chemoresistant cells associated with EMT. Notably, we found miR-155 induction in exosomes isolated from CSCs and resistant cells, followed by resistant cells’ exosome transfer to the recipient sensitive cells. Functionally, miR-155 mimic assay showed an enrichment in miR-155 from exosome concomitant with miR-155 exosome transfer to breast cancer cells. In parallel to these effects, we also observed EMT change in miR-155 transfected cells. The chemoresistance phenotype transfer to sensitive cells and the migration capability was analyzed by MTT and scratch assays and our results suggest that exosomes may intermediate resistance and migration capacity to sensitive cells partly through exosome transfer of miR-155. Taken together, our findings establish the significance of exosome-mediate miR-155 chemoresistance in breast cancer cells, with implications for targeting miR-155 signaling as a possible therapeutic strategy.

14 November 2016 in Cancer Research
Verified
Journal Article
Open access
PDF file
JSJuliana Santos
Juliana Santos
ECEstefania Carrasco-Garcia
Estefania Carrasco-Garcia
MGMikel García-Puga
Mikel García-Puga
PAPaula Aldaz
Paula Aldaz
MMMilagrosa Montes
Milagrosa Montes
Ander MatheuAnder Matheu
Ander Matheu
Gastric cancer remains one of the leading causes of global cancer mortality due to therapy resistance, with Helicobacter pylori (H. pylori) infection being a major risk factor. In this study, we report the significance of an elevation of the stem cell regulator SOX9 in bacteria-infected human gastritis and cancer samples, paralleling increased levels of TNFα. SOX9 elevation was more intense in specimens containing the pathogenically significant cagA+ strains of H. pylori. Notably, we found that SOX9 was required for bacteria-induced gastric cancer cell proliferation, increased levels of β-catenin, and acquisition of stem cell–like properties. Analysis of three large clinical cohorts revealed elevated SOX9 levels in gastric cancer with advanced tumor stage and poor patient survival. Functionally, SOX9 silencing in gastric cancer cells enhanced apoptosis and senescence, concomitantly with a blockade to self-renewal and tumor-initiating capability. Paralleling these effects, we also found SOX9 to mediate cisplatin chemoresistance associated with reduced disease-free survival. Mechanistic interactions between SOX9 and β-catenin expression suggested the existence of a regulatory role for SOX9 targeting the WNT canonical pathway. Taken together, our findings establish the significance of SOX9 in gastric cancer pathobiology and heterogeneity, with implications for targeting WNT–SOX9 signaling as a rational therapeutic strategy. Cancer Res; 76(22); 6735–46. ©2016 AACR.

3 April 2023 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
MSMarie Sabatier
Marie Sabatier
RBRudy Birsen
Rudy Birsen
LLLaura Lauture
Laura Lauture
SMSarah Mouche
Sarah Mouche
PAPaolo Angelino
Paolo Angelino
JSJean-Emmanuel Sarry
Jean-Emmanuel Sarry
Although transcription factor CCAAT-enhancer binding protein α (C/EBPα) is critical for normal and leukemic differentiation, its role in cell and metabolic homeostasis is largely unknown in cancer. Here, multiomics analyses uncovered a coordinated activation of C/EBPα and Fms-like tyrosine kinase 3 (FLT3) that increased lipid anabolism in vivo and in patients with FLT3-mutant acute myeloid leukemia (AML). Mechanistically, C/EBPα regulated the fatty acid synthase (FASN)–stearoyl-CoA desaturase (SCD) axis to promote fatty acid (FA) biosynthesis and desaturation. We further demonstrated that FLT3 or C/EBPα inactivation decreased monounsaturated FA incorporation to membrane phospholipids through SCD downregulation. Consequently, SCD inhibition enhanced susceptibility to lipid redox stress that was exploited by combining FLT3 and glutathione peroxidase 4 inhibition to trigger lipid oxidative stress, enhancing ferroptotic death of FLT3-mutant AML cells. Altogether, our study reveals a C/EBPα function in lipid homeostasis and adaptation to redox stress, and a previously unreported vulnerability of FLT3-mutant AML to ferroptosis with promising therapeutic application. Significance: FLT3 mutations are found in 30% of AML cases and are actionable by tyrosine kinase inhibitors. Here, we discovered that C/EBPα regulates FA biosynthesis and protection from lipid redox stress downstream mutant-FLT3 signaling, which confers a vulnerability to ferroptosis upon FLT3 inhibition with therapeutic potential in AML. This article is highlighted in the In This Issue feature, p. 1501

1 November 2013 in Food Chemistry
Verified
Journal Article
Closed access
DADemétrius Paiva Arçari
Demétrius Paiva Arçari
JSJuliana Santos
Juliana Santos
AGAlessandra Gambero
Alessandra Gambero
MRMarcelo Ribeiro
Marcelo Ribeiro

28 April 2012 in Plant Foods for Human Nutrition
Verified
Journal Article
Closed access
PDF file
GGGrace Gosmann
Grace Gosmann
ABAdriana Gregory Barlette
Adriana Gregory Barlette
TDTabitha Dhamer
Tabitha Dhamer
DADemétrius P. Arçari
Demétrius P. Arçari
JSJuliana Santos
Juliana Santos
MRMarcelo Ribeiro
Marcelo Ribeiro

1 September 2012 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
PDF file
JSJuliana Santos
Juliana Santos
MLM.S.P. Ladeira
M.S.P. Ladeira
JJJ. Pedrazzoli Jr
J. Pedrazzoli Jr
MRMarcelo Ribeiro
Marcelo Ribeiro
It is well known that the risk of development of gastric cancer (GC) in Helicobacter pylori-infected patients depends on several factors. Thus, the aim of this study was to investigate the effect of proinflammatory cytokine gene polymorphisms for IL-1β, IL-1RN and TNF-α on the development of GC in a Brazilian population. A total of 202 biopsies obtained from Brazilian patients with chronic gastritis and GC were included in the study. Infection with H. pylori cagA+ was determined by the polymerase chain reaction (PCR) as previously described. IL-1β, IL-1RN and TNF-α polymorphism genotyping was performed by restriction fragment length polymorphism PCR. Associations between gene polymorphisms, clinical diseases and virulence markers were evaluated using either the χ² test or the Fisher exact test. Our results demonstrated that the IL-1β -511 C/C and IL-1β -511 C/T alleles were associated with chronic gastritis in H. pylori-positive patients (P = 0.04 and P = 0.05, respectively) and the IL-1β -511 C/C genotype was associated with GC (P = 0.03). The frequency of IL-1RN alleles from patients with chronic gastritis and GC indicated that there was no difference between the genotypes of the groups studied. Similar results were found for TNF-α -308 gene polymorphisms. Our results indicate that the IL-1β -511 C/C and C/T gene polymorphisms are associated with chronic gastritis and GC development in H. pylori-infected individuals.